Artificial Oxygen Carriers – a Critical Analysis

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Transfusion Medicine and Hemotherapy

• Publication date

  2002-06-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1159/000064237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• New artificial oxygen carriers made of pegulated polymerised pyridoxylated porcine haemoglobin (P(4)Hb).

  2002cited by this paper
• The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers.

  2001cited by this paper
• Oxygen therapeutics--current concepts.

  2001cited by this paper
• Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery.

  2001cited by this paper
• A SYSTEM ESTABLISHING COMPATIBILITY PROFILES FOR ARTIFICIAL OXYGEN CARRIERS AND OTHER SUBSTANCES

  2001cited by this paper
• A system establishment compatibility profiles for artificial oxygen carriers and other substances.

  2001cited by this paper
• Blood product from cattle wins approval for use in humans

  2001cited by this paper
• Red Blood Cell Substitutes

  2001cited by this paper
• Preparation and characterization of SNO-PEG-hemoglobin as a candidate for oxygen transporting material

  2001cited by this paper
• Absence of immunopathology associated with repeated IV administration of bovine Hb‐based oxygen carrier in dogs

  2001cited by this paper
• αα–Crosslinked Hemoglobin: Was Failure Predicted by Preclinical Testing?

  2000cited by this paper
• αα‐Crosslinked Hemoglobin: Was Failure Predicted by Preclinical Testing?

  2000cited by this paper
• Haemoglobin-based oxygen carriers

  2000cited by this paper
• Pyridoxalated hemoglobin polyoxyethylene: a nitric oxide scavenger with antioxidant activity for the treatment of nitric oxide-induced shock.

  2000cited by this paper
• Novel recombinant hemoglobin, rHb (beta N108Q), with low oxygen affinity, high cooperativity, and stability against autoxidation.

  2000cited by this paper
• Endothelin plays a role in contractions of isolated pig pulmonary vessels induced by diaspirin cross-linked hemoglobin.

  1999cited by this paper
• Modified hemoglobins produce venular interendothelial gaps and albumin leakage in the rat mesentery.

  1999cited by this paper
• Nonpeptide endothelin receptor antagonists attenuate the pressor effect of diaspirin-crosslinked hemoglobin in rat.

  1999cited by this paper
• Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke.

  1999cited by this paper
• Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Treatment of Severe Traumatic Hemorrhagic Shock: A Randomized Controlled Efficacy Trial

  1999cited by this paper
• Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute.

  1999cited by this paper
• Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group.

  1999cited by this paper
• Liquid ventilation: clinical experiences.

  1999cited by this paper
• Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance.

  1998cited by this paper
• EFFECT OF LIPOSOME‐ENCAPSULATED HEMOGLOBIN ON THE DEVELOPMENT OF ENDOTOXIN‐INDUCED SHOCK IN THE RAT

  1998cited by this paper
• Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin

  1998cited by this paper
• Absence of immunogenicity of diaspirin cross-linked hemoglobin in humans.

  1998cited by this paper
• The Effects of Increased Doses of Bovine Hemoglobin on Hemodynamics and Oxygen Transport in Patients Undergoing Preoperative Hemodilution for Elective Abdominal Aortic Surgery

  1998cited by this paper
• Arterial Blood Pressure Responses to Cell-free Hemoglobin Solutions and the Reaction with Nitric Oxide*

  1998cited by this paper
• Partial liquid ventilation in adult patients with ARDS: A multicenter phase I-II trial

  1998cited by this paper
• Effect of diaspirin cross‐linked hemoglobin on endothelin‐1 and blood pressure in acute ischemic stroke in man

  1998cited by this paper
• Clinical experience with AF0150 (Imagent US), a new ultrasound contrast agent.

  1998cited by this paper
• The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery.

  1998cited by this paper
• Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat.

  1997cited by this paper
• Oxalated pyridoxalated hemoglobin polyoxyethylene conjugate normalizes the hyperdynamic circulation in septic sheep.

  1997cited by this paper
• Hemoglobin increases mortality from bacterial endotoxin

  1997cited by this paper
• Interactions of recombinant hemoglobin (rHb1.1) and endotoxin in vivo: effects on systemic tumor necrosis factor and interleukin-6 levels in lethal and sublethal murine models of endotoxemia.

  1997cited by this paper
• Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization.

  1996cited by this paper
• Clinical Development of Human Polymerized Hemoglobin as a Blood Substitute

  1996cited by this paper
• Inhibition of endothelium-dependent relaxation by hemoglobin in rabbit aortic strips: comparison between acellular hemoglobin derivatives and cellular hemoglobins.

  1996cited by this paper
• Blood substitutes : physiological basis of efficacy

  1995cited by this paper
• Microcirculatory Consequences of Blood Substitution with αα-Hemoglobin

  1995cited by this paper
• Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions.

  1995cited by this paper
• Clinical Development of Perfluorocarbon-based Emulsions as Red Cell Substitutes

  1995cited by this paper
• A Theoretical Analysis of Oxygen Transport: A New Strategy for the Design of Hemoglobin-Based Red Cell Substitutes

  1995cited by this paper
• Evaluation of the immunogenicity of polymerized hemoglobin solutions in a rabbit model.

  1995cited by this paper
• Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives.

  1995cited by this paper
• Diaspirin crosslinked hemoglobin (DCLHb): bioanalytical studies in swine.

  1994cited by this paper
• Intravenous Fluosol in the Treatment of Acute Myocardial Infarction: Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial

  1994cited by this paper
• Methemoglobin formation after administration of hemoglobin conjugated to carboxylate dextran in guinea pigs. Attempts to prevent the oxidation of hemoglobin.

  1994cited by this paper
• Reaction of human endothelial cells to bovine hemoglobin solutions and tumor necrosis factor.

  1994cited by this paper
• Phagocytosis of colloidal carbon after administration of perfluorochemicals of first and second generation.

  1994cited by this paper
• Enzymatic protection from autoxidation for crosslinked hemoglobins.

  1994cited by this paper
• Perfluorocarbons as blood substitutes: the early years. Experience with Fluosol DA-20% in the 1980s.

  1994cited by this paper
• Recombinant hemoglobin A produced in transgenic swine: structural equivalence with human hemoglobin A.

  1994cited by this paper
• Hemoglobin-based Red Cell Substitutes

  1993cited by this paper
• Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.

  1992cited by this paper
• Immunological effects of hemoglobin, encapsulated hemoglobin, polyhemoglobin and conjugated hemoglobin using different immunization schedules.

  1992cited by this paper
• A human recombinant haemoglobin designed for use as a blood substitute

  1992cited by this paper
• Complement activation by artificial blood substitute Fluosol: in vitro and in vivo studies

  1991cited by this paper
• Perfluorochemical emulsions decrease Kupffer cell phagocytosis

  1991cited by this paper
• Synergistic toxicity of endotoxin and hemoglobin.

  1986cited by this paper
• Serum Antibody Titers in Rats Receiving Repeated Small Subcutaneous Injections of Hemoglobin or Polyhemoglobin: A Preliminary Report

  1986cited by this paper
• Development and Clinical Application of Perfluorochemical Artificial Blood

  1986cited by this paper
• Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases.

  1982cited by this paper

• Perfluorocarbons for the treatment of decompression illness: how to bridge the gap between theory and practice

  2019cites this paper
• Perfluorocarbons in photodynamic and photothermal therapy

  2017cites this paper
• Biologische Verträglichkeit künstlicher Sauerstoffträger auf Perfluorcarbon-Basis

  2014cites this paper
• High O2 affinity hemoglobin‐based oxygen carriers synthesized via polymerization of hemoglobin with ring‐opened 2‐chloroethyl‐β‐D‐fructopyranoside and 1‐o‐octyl‐β‐D‐glucopyranoside

  2007influential citation
• Synthesis, characterization, and modeling of novel bovine hemoglobin-based oxygen carriers

  2007influential citation
• Oxidized Mono‐, Di‐, Tri‐, and Polysaccharides as Potential Hemoglobin Cross‐Linking Reagents for the Synthesis of High Oxygen Affinity Artificial Blood Substitutes

  2004cites this paper
• Effect of Glutaraldehyde Concentration on the Physical Properties of Polymerized Hemoglobin‐Based Oxygen Carriers

  2004cites this paper